Jump to main content
Jump to site search

Issue 44, 2017
Previous Article Next Article

Taurine-modified Ru(II)-complex targets cancerous brain cells for photodynamic therapy

Author affiliations

Abstract

The precision and efficacy of photodynamic therapy (PDT) is essential for the treatment of brain tumors because the cancer cells are within or adjacent to the delicate nervous system. Taurine is an abundant amino acid in the brain that serves the central nervous system (CNS). A taurine-modified polypyridyl Ru-complex was shown to have optimized intracellular affinity in cancer cells through accumulation in lysosomes. Symmetrical modification of this Ru-complex by multiple taurine molecules enhanced the efficiency of molecular emission with boosted generation of reactive oxygen species. These characteristic features make the taurine-modified Ru-complex a potentially effective photosensitizer for PDT of target cancer cells, with outstanding efficacy in cancerous brain cells.

Graphical abstract: Taurine-modified Ru(ii)-complex targets cancerous brain cells for photodynamic therapy

Back to tab navigation

Supplementary files

Publication details

The article was received on 29 Apr 2017, accepted on 08 May 2017 and first published on 08 May 2017


Article type: Communication
DOI: 10.1039/C7CC03337K
Citation: Chem. Commun., 2017,53, 6033-6036
  •   Request permissions

    Taurine-modified Ru(II)-complex targets cancerous brain cells for photodynamic therapy

    E. Du, X. Hu, S. Roy, P. Wang, K. Deasy, T. Mochizuki and Y. Zhang, Chem. Commun., 2017, 53, 6033
    DOI: 10.1039/C7CC03337K

Search articles by author

Spotlight

Advertisements